GlobeNewswire Inc.··Greenwich Lifesciences, Inc.Greenwich LifeSciences Scales GP2 Production as Phase III Trial Hits Manufacturing Milestone
Greenwich LifeSciences deploys commercially manufactured GP2 across all 40 FLAMINGO-01 trial sites following FDA approval, scaling production capacity significantly.
GLSIFDA approvalcommercial manufacturing